Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 8 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vigil Neuroscience, Inc. | 1,556,030 | reported | 17 May 2022 | tx 7+1,559,030−3,478,527 |
| Clearside Biomedical, Inc. | 176,141 | reported | 24 Feb 2025 | tx 68+5,921,957−9,580,248 |
| PhaseBio Pharmaceuticals Inc | 0 | reported | 19 May 2023 | tx 60+2,709,502−2,330,464 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Feb 2025 | PURCHASE | Clearside Biomedical, Inc. | 15,000 | 0.92 USD | first after silence |
| 20 Jun 2024 | GRANT_AWARD | Clearside Biomedical, Inc. | 45,000 | 0.00 USD | deriv |
| 25 Sept 2023 | PURCHASE | Clearside Biomedical, Inc. | 10,000 | 0.86 USD | |
| 22 Jun 2023 | GRANT_AWARD | Clearside Biomedical, Inc. | 30,000 | 0.00 USD | deriv |
| 19 May 2023 | EXERCISE | PhaseBio Pharmaceuticals Inc | 3,750 | — | |
| 19 May 2023 | EXERCISE | PhaseBio Pharmaceuticals Inc | 3,750 | 0.00 USD | deriv |
| 21 Dec 2022 | PURCHASE | Clearside Biomedical, Inc. | 14,000 | 1.02 USD | |
| 15 Dec 2022 | OTHER | Clearside Biomedical, Inc. | 1,406,507 | 0.00 USD | |
| 15 Dec 2022 | OTHER | Clearside Biomedical, Inc. | 8,522 | 0.00 USD | |
| 22 Jun 2022 | GRANT_AWARD | Clearside Biomedical, Inc. | 30,000 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 3,750 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 17,500 | 0.00 USD | deriv |
| 17 May 2022 | PURCHASE | Vigil Neuroscience, Inc. | 14,893 | 2.97 USD | |
| 16 May 2022 | PURCHASE | Vigil Neuroscience, Inc. | 21,802 | 2.76 USD | |
| 28 Mar 2022 | PURCHASE | Vigil Neuroscience, Inc. | 3,000 | 7.20 USD | |
| 11 Jan 2022 | CONVERSION | Vigil Neuroscience, Inc. | 1,254,335 | — | |
| 11 Jan 2022 | PURCHASE | Vigil Neuroscience, Inc. | 265,000 | 14.00 USD | anomaly |
| 11 Jan 2022 | CONVERSION | Vigil Neuroscience, Inc. | 926,506 | 0.00 USD | deriv |
| 11 Jan 2022 | CONVERSION | Vigil Neuroscience, Inc. | 2,552,021 | 0.00 USD | deriv |
| 18 Aug 2021 | PURCHASE | PhaseBio Pharmaceuticals Inc | 10,000 | 3.00 USD | |
| 10 Jun 2021 | GRANT_AWARD | Clearside Biomedical, Inc. | 25,000 | 0.00 USD | deriv |
| 03 Jun 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 14,000 | 0.00 USD | deriv |
| 10 Feb 2021 | SALE | Clearside Biomedical, Inc. | 32,873 | 4.43 USD | |
| 23 Nov 2020 | PURCHASE | PhaseBio Pharmaceuticals Inc | 3,000 | 3.67 USD | first after silence |
| 24 Nov 2020 | PURCHASE | PhaseBio Pharmaceuticals Inc | 2,000 | 3.50 USD |
3 purchases reported after at least 12 months of silence — most recent on 24 Feb 2025.